Login to Your Account

Genentech, Seattle Genetics Collaborate In Antibody Program

By Kim Coghill

Tuesday, April 23, 2002
Genentech Inc. will strengthen its long-standing relationship with Seattle Genetics Inc. by paying up to $50 million for access to technology to build its cancer program.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription